[1]
2019. DESIGN, SYNTHESIS AND ANTICANCER ACTIVITY OF STRUCTURALLY MODIFIED 1, 3, 4-OXADIAZOLE INCORPORATED 2H-CHROMENE DERIVATIVES AS ANTICANCER AGENTS . International Research Journal of Pharmacy. 10, 10 (Oct. 2019), 87–92.